CD8A and neoplasm: In regards to T cells, it is well known that the cytotoxic activity of CD8 T cells is the goal of antitumoral responses and is the ground for tumor-infiltrating lymphocytes (TIL) therapy and chimeric antigen receptor-T CAR-T cell therapy (140).